EXCLUSIVE: Skin Pharm Lands Minority Investment From Prelude Growth Partners

  • 📰 wwd
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

The $15 million investment will help fuel Skin Pharm's expansion plans.

“Now is the perfect time to take this investment because we have this amazing team, we built a trustworthy brand, and we have a loyal community of customers who are wanting to grow with us,” Griffin told WWD in an interview. “Now, we know that we can grow at a more rapid rate with this capital, while being mindful of maintaining the culture and the quality of care that Skin Pharm has been known for.

Skin Pharm has five clinics in Nashville and Franklin, Tennessee; Atlanta; Charlotte, North Carolina; and Dallas, with Alpharetta, Georgia; and Houston slated to open in the coming months.The business also has its own skin care line, launched in 2018, which now has close to 20 products, including Crystal Clear Clarifying Pads, $50, Youth Serum, $115, and Glow Factor, $150. Griffin plans to continue to expand its product offering. The line is sold in clinics and on Skin Pharm’s website.

Prelude also has investments in Summer Fridays, Westman Atelier, Blueland and The Center, among other brands. In 2021, Sol de Janeiro, which the firm backed, was acquired by L’Occitane at a $450 million valuation.Among some of the deals, millennial med spa Ever/Body, which offers laser facials, Botox, HydraFacial, fillers and laser hair removal, raised a $38 million series B from a mix of investors including Tiger Global Management, Addition and Fifth Wall, and later a $55.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 24. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines